Randomized trial: immunogenicity and safety of coadministered human papillomavirus-16/18 AS04-adjuvanted vaccine and combined hepatitis A and B vaccine in girls

Court Pedersen; Morten  Breindahl; Naresh Aggarwal; Johan Berglund; György Oroszlán; Sven Arne Silfverdal; Péter Szüts; Michael O'Mahony; Marie-Pierre David; Kurt Dobbelaere; Gary Dubin; Dominique Descamps

doi:10.1016/j.jadohealth.2011.10.009

Randomized trial: immunogenicity and safety of coadministered human papillomavirus-16/18 AS04-adjuvanted vaccine and combined hepatitis A and B vaccine in girls

Court Pedersen, Morten Breindahl, Naresh Aggarwal, Johan Berglund, György Oroszlán, Sven Arne Silfverdal, Péter Szüts, Michael O'Mahony, Marie-Pierre David, Kurt Dobbelaere, Gary Dubin, Dominique Descamps

Afdeling for Intensiv behandling af nyfødte og mindre børn

26 Citationer (Scopus)

Abstrakt

This randomized, open, controlled, multicenter study (110886/NCT00578227) evaluated human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine (HPV-16/18 vaccine) coadministered with inactivated hepatitis A and B (HAB) vaccine. Coprimary objectives were to demonstrate noninferiority of hepatitis A, hepatitis B, and HPV-16/18 immune responses at month 7 when vaccines were coadministered, compared with the same vaccines administered alone.

Originalsprog	Engelsk
Tidsskrift	Journal of Adolescent Health
Vol/bind	50
Udgave nummer	1
Sider (fra-til)	38-46
Antal sider	9
ISSN	1054-139X
DOI	https://doi.org/10.1016/j.jadohealth.2011.10.009
Status	Udgivet - 2012

Adgang til dokumentet

10.1016/j.jadohealth.2011.10.009

Citationsformater

Pedersen, C., Breindahl, M., Aggarwal, N., Berglund, J., Oroszlán, G., Silfverdal, S. A., Szüts, P., O'Mahony, M., David, M-P., Dobbelaere, K., Dubin, G., & Descamps, D. (2012). Randomized trial: immunogenicity and safety of coadministered human papillomavirus-16/18 AS04-adjuvanted vaccine and combined hepatitis A and B vaccine in girls. Journal of Adolescent Health, 50(1), 38-46. https://doi.org/10.1016/j.jadohealth.2011.10.009

Randomized trial: immunogenicity and safety of coadministered human papillomavirus-16/18 AS04-adjuvanted vaccine and combined hepatitis A and B vaccine in girls. / Pedersen, Court; Breindahl, Morten ; Aggarwal, Naresh et al.

I: Journal of Adolescent Health, Bind 50, Nr. 1, 2012, s. 38-46.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Pedersen, C, Breindahl, M, Aggarwal, N, Berglund, J, Oroszlán, G, Silfverdal, SA, Szüts, P, O'Mahony, M, David, M-P, Dobbelaere, K, Dubin, G & Descamps, D 2012, 'Randomized trial: immunogenicity and safety of coadministered human papillomavirus-16/18 AS04-adjuvanted vaccine and combined hepatitis A and B vaccine in girls', Journal of Adolescent Health, bind 50, nr. 1, s. 38-46. https://doi.org/10.1016/j.jadohealth.2011.10.009

@article{e172a9ddd32f447595948522fbd4a076,

title = "Randomized trial: immunogenicity and safety of coadministered human papillomavirus-16/18 AS04-adjuvanted vaccine and combined hepatitis A and B vaccine in girls",

abstract = "This randomized, open, controlled, multicenter study (110886/NCT00578227) evaluated human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine (HPV-16/18 vaccine) coadministered with inactivated hepatitis A and B (HAB) vaccine. Coprimary objectives were to demonstrate noninferiority of hepatitis A, hepatitis B, and HPV-16/18 immune responses at month 7 when vaccines were coadministered, compared with the same vaccines administered alone.",

author = "Court Pedersen and Morten Breindahl and Naresh Aggarwal and Johan Berglund and Gy{\"o}rgy Oroszl{\'a}n and Silfverdal, {Sven Arne} and P{\'e}ter Sz{\"u}ts and Michael O'Mahony and Marie-Pierre David and Kurt Dobbelaere and Gary Dubin and Dominique Descamps",

year = "2012",

doi = "10.1016/j.jadohealth.2011.10.009",

language = "English",

volume = "50",

pages = "38--46",

journal = "Journal of Adolescent Health",

issn = "1054-139X",

publisher = "Elsevier",

number = "1",

}

TY - JOUR

T1 - Randomized trial: immunogenicity and safety of coadministered human papillomavirus-16/18 AS04-adjuvanted vaccine and combined hepatitis A and B vaccine in girls

AU - Pedersen, Court

AU - Breindahl, Morten

AU - Aggarwal, Naresh

AU - Berglund, Johan

AU - Oroszlán, György

AU - Silfverdal, Sven Arne

AU - Szüts, Péter

AU - O'Mahony, Michael

AU - David, Marie-Pierre

AU - Dobbelaere, Kurt

AU - Dubin, Gary

AU - Descamps, Dominique

PY - 2012

Y1 - 2012

N2 - This randomized, open, controlled, multicenter study (110886/NCT00578227) evaluated human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine (HPV-16/18 vaccine) coadministered with inactivated hepatitis A and B (HAB) vaccine. Coprimary objectives were to demonstrate noninferiority of hepatitis A, hepatitis B, and HPV-16/18 immune responses at month 7 when vaccines were coadministered, compared with the same vaccines administered alone.

AB - This randomized, open, controlled, multicenter study (110886/NCT00578227) evaluated human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine (HPV-16/18 vaccine) coadministered with inactivated hepatitis A and B (HAB) vaccine. Coprimary objectives were to demonstrate noninferiority of hepatitis A, hepatitis B, and HPV-16/18 immune responses at month 7 when vaccines were coadministered, compared with the same vaccines administered alone.

U2 - 10.1016/j.jadohealth.2011.10.009

DO - 10.1016/j.jadohealth.2011.10.009

M3 - Journal article

C2 - 22188832

VL - 50

SP - 38

EP - 46

JO - Journal of Adolescent Health

JF - Journal of Adolescent Health

SN - 1054-139X

IS - 1

ER -

Randomized trial: immunogenicity and safety of coadministered human papillomavirus-16/18 AS04-adjuvanted vaccine and combined hepatitis A and B vaccine in girls

Abstrakt

Adgang til dokumentet

Fingeraftryk

Citationsformater